About multi-drug-resistant bacteria monitoring, what is included

The details are as follows:

Strengthening the implementation of targeted surveillance of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), ultra broad-spectrum β-lactamase-producing bacteria (ESBLs), and multi-drug-resistant Acinetobacter baumannii.

Timely detection and early diagnosis of patients infected with multidrug-resistant bacteria and patients with colonization, strengthening the microbiology laboratory's detection of multidrug-resistant bacteria and its monitoring of antimicrobial drug susceptibility and resistance patterns, and guiding the clinical control of multidrug-resistant bacterial hospital-acquired infections according to the results of the monitoring.

Multi-drug-resistant organisms (MDRO) mainly refer to bacteria that are resistant to three or more classes of antimicrobial drugs used in the clinic at the same time, and the most common ones are methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecalis (VRE), ultraspectral β-lactamase-producing (ESBLS)-producing bacteria, carbapenem-resistant Enterobacteriaceae (CRE), carbapenem-resistant Enterobacteriaceae (CR), and carbapenem-resistant Acinetobacter baumannii (CR), and so on. drug-resistant Acinetobacter baumannii (CR-AS), multidrug-resistant/pan-drug-resistant Pseudomonas aeruginosa (MDR/PDR-PA) and multidrug-resistant Mycobacterium tuberculosis.

Antimicrobial drugs have played a key role in the process of human victory over various infectious diseases, but due to the irrational use of antimicrobial drugs_immunosuppressant applications and invasive operations carried out, resulting in multi-drug-resistant organisms (MORO) infections are becoming increasingly serious, due to the existence of multi-drug-resistant bacteria are ineffective against a variety of antimicrobial drugs, and are often localized in the body of the patient to form the potential source of infection, so that Once the infection or transmission occurs in the hospital, it will be very difficult to control, bringing great pressure to the treatment and prevention and control.

/iknow-pic.cdn.bcebos.com/9213b07eca806538c7fe017c9adda144ad34824d "target="_blank "title=""class="ikqb_img_alink">/iknow- pic.cdn.bcebos.com/9213b07eca806538c7fe017c9adda144ad34824d?x-bce-process=image%2Fresize%2Cm_lfit%2Cw_600%2Ch_800%2Climit_1% 2Fquality%2Cq_85%2Fformat%2Cf_auto "esrc="/mohyzs/s3593/200807/37328.shtml "target="_blank "title="Ministry of Health Notice on Strengthening Hospital Infection Control of Multi-Drug-Resistant Bacteria-National Health Commission"> ;Notice of the Ministry of Health on Strengthening Hospital Infection Control of Multi-Drug-Resistant Bacteria-National Health and Wellness Commission